Mitochondrial Dysfunction in Parkinson’s Disease: Potential Applications for Cybrid Modeling of the Disease

[1]  Robert E. Davis,et al.  Altered Calcium Homeostasis in Cells Transformed by Mitochondria from Individuals with Parkinson's Disease , 1997, Journal of neurochemistry.

[2]  G. Wooten,et al.  Maternal inheritance in Parkinson's disease , 1997, Annals of neurology.

[3]  M. Leehey,et al.  Platelet mitochondrial respiratory chain function in Parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[4]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.

[5]  Robert Hill,et al.  Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.

[6]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[7]  T. Ozawa,et al.  Point mutations of mitochondrial genome in Parkinson's disease. , 1995, Brain research. Molecular brain research.

[8]  S. Miyazaki,et al.  Fas antigen-mediated DNA fragmentation and apoptotic morphologic changes are regulated by elevated cytosolic Ca2+ level. , 1995, Journal of immunology.

[9]  O. Blin,et al.  Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy , 1994, Journal of the Neurological Sciences.

[10]  C. Marsden,et al.  Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study , 1994, Movement disorders : official journal of the Movement Disorder Society.

[11]  Samuel Thayer,et al.  Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  M. Yahr,et al.  Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease , 1994, Journal of neural transmission. Parkinson's disease and dementia section.

[13]  R. Benecke,et al.  Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. , 1993, Brain : a journal of neurology.

[14]  C. Marín,et al.  Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease , 1993, Neurology.

[15]  N. Savarese,et al.  Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients , 1993, Neurology.

[16]  B. Crain,et al.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.

[17]  D. Choi,et al.  Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  T. Chase,et al.  No evidence for altered muscle mitochondrial function in Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[19]  J. Molina,et al.  Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. , 1993, Clinical chemistry.

[20]  E. Hirsch,et al.  Glutathione peroxidase, glial cells and Parkinson's disease , 1993, Neuroscience.

[21]  D. D. Di Monte,et al.  PCR Analysis of platelet mtDNA: Lack of specific changes in Parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[22]  C. Marsden,et al.  Mitochondrial function in Parkinson's disease , 1992, Annals of neurology.

[23]  S. Orrenius,et al.  Ca2+ and Cell Death a , 1992, Annals of the New York Academy of Sciences.

[24]  C. Marsden,et al.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.

[25]  J. Cooper,et al.  Quantitation of a mitochondrial DNA deletion in Parkinson's disease , 1992, FEBS letters.

[26]  S. Horai,et al.  Is Parkinson's disease a mitochondrial disorder? , 1992, Journal of the Neurological Sciences.

[27]  A. Torroni,et al.  Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.

[28]  H. Yoshino,et al.  Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[29]  D. Turnbull,et al.  Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.

[30]  K. Jellinger,et al.  Mitochondrial DNA in Postmortem Brain from Patients with Parkinson's Disease , 1991, Journal of neurochemistry.

[31]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[32]  K. Jellinger,et al.  Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect , 1990, Journal of neurochemistry.

[33]  K. Ohno,et al.  Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. , 1990, Biochemical and biophysical research communications.

[34]  A. Schapira,et al.  Mitochondrial DNA analysis in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[35]  C. Marsden,et al.  Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.

[36]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[37]  Y. Kagawa,et al.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.

[38]  C. Marsden,et al.  A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.

[39]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[40]  Sangkot Marzuki,et al.  MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.

[41]  T. Ozawa,et al.  Hypothesis. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases , 1989 .

[42]  R. Marttila,et al.  Oxygen toxicity protecting enzymes in Parkinson's disease Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus , 1988, Journal of the Neurological Sciences.

[43]  J W Langston,et al.  Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys , 1986, Annals of neurology.

[44]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[45]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.